MGI Tech Singapore Pte, Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore (“NCCS”) to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI’s core DNBSEQ™ technology.
MoU signed to develop mRNA production platform in Egypt
EVA Pharma, DNA Script and Quantoom Biosciences signed the MoU. Credit: © 2022 Eva Pharma All Rights Reserved. EVA Pharma of Africa, DNA Script and